Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership3,259 shares
Latest Disclosed Value $ 70,916
Walleye Trading LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 3,259 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $70,916 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 15,456 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -78.91% during the quarter.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 9,100 of underlying shares valued at $198,016 USD and put options representing 5,200 of underlying shares valued at $113,152 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 3,259 -12,197 -78.91 71 -78.92 0.0001
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 15,456 3,228 26.40 333 41.28 0.0005
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 12,228 8,569 234.19 236 279.03 0.0004
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 3,659 3,659 63 0.0001
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -622 -100.00 0 -100.00
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 622 0 0.00 76 -2.60 0.0002
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 622 -17,426 -96.55 78 -97.30 0.0002
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 18,048 8,030 80.16 2,852 119.98 0.0068
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 10,018 -29,355 -74.56 1,297 -65.86 0.0028
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 39,373 9,551 32.03 3,797 5.01 0.0082
2023-11-21 2023-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 29,822 29,822 3,615 0.0095
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 29,822 29,822 3,615 0.0096
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -12,569 -100.00 0 -100.00
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 12,569 12,569 1,732 0.0038
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -30,000 -100.00 0 -100.00
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 30,000 30,000 3,316 0.0101
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -968 -100.00 0 -100.00
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 968 968 87 0.0003
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -1,427 -100.00 0 -100.00
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,427 -1,699 -54.35 111 -52.36 0.0004
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 3,126 3,126 233 0.0010
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -18,721 -100.00 0 -100.00
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 18,721 18,721 1,831 0.0141
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -16,500 -100.00 0 -100.00
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 16,500 14,301 650.34 2,507 856.87 0.0216
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 2,199 1,611 273.98 262 309.38 0.0020
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 588 -557 -48.65 64 -65.41 0.0005
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,145 -6,715 -85.43 185 -82.19 0.0010
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 7,860 7,860 1,039 0.0056
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -2,300 -100.00 0 -100.00
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 2,300 2,300 44 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM Call 9,100 -74.07 198 -73.77 n/a n/a n/a
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM Call 35,100 67.14 755 86.88 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Call 21,000 -81.94 405 -79.68 n/a n/a n/a
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Call 116,300 1,989 n/a n/a n/a
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM Call 4,600 -74.86 559 -75.54 n/a n/a n/a
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM Call 18,300 -63.91 2,285 -71.47 n/a n/a n/a
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM Call 50,700 558.44 8,011 704.22 n/a n/a n/a
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM Call 7,700 -53.05 997 -37.00 n/a n/a n/a
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Call 16,400 -47.60 1,581 -58.33 n/a n/a n/a
2023-11-21 2023-09-30 13F/A SAREPTA THERAPEUTICS COM Call 31,300 -19.33 3,794 -14.61 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Call 31,300 3,794 n/a n/a n/a
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM Call 38,800 -53.81 4,443 -61.62 n/a n/a n/a
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM Call 84,000 50.54 11,578 60.12 n/a n/a n/a
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM Call 55,800 -4.62 7,231 11.80 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM Call 58,500 6,467 n/a n/a n/a
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM Call 12,100 49.38 1,090 45.53 n/a n/a n/a
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM Call 8,100 -59.90 749 -52.29 n/a n/a n/a
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS COM Call 20,200 27.85 1,570 33.28 n/a n/a n/a
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS COM Call 15,800 198.11 1,178 30.31 n/a n/a n/a
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM Call 5,300 -66.03 904 -58.74 n/a n/a n/a
2020-11-16 2020-09-30 13F SAREPTA THERAPEUTICS COM Call 15,600 10.64 2,191 -3.10 n/a n/a n/a
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS COM Call 14,100 11.02 2,261 82.05 n/a n/a n/a
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM Call 12,700 -88.05 1,242 -90.95 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Call 106,300 1,587.30 13,717 2,787.79 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Call 6,300 2,000.00 475 932.61 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Call 300 -75.00 46 -67.83 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM Call 1,200 -70.73 143 -68.01 n/a n/a n/a
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM Call 4,100 57.69 447 6.43 n/a n/a n/a
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM Call 2,600 225.00 420 296.23 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM Call 800 106 n/a n/a n/a
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM Call 4,000 246 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F SAREPTA THERAPEUTICS COM Put 5,200 -91.50 113 -91.42 n/a n/a n/a
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM Put 61,200 65.41 1,317 84.97 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Put 37,000 -27.17 713 -17.97 n/a n/a n/a
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Put 50,800 869 n/a n/a n/a
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM Put 6,000 76.47 730 71.93 n/a n/a n/a
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM Put 3,400 -92.27 425 -93.90 n/a n/a n/a
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM Put 44,000 158.82 6,952 216.00 n/a n/a n/a
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM Put 17,000 -32.54 2,201 -9.47 n/a n/a n/a
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Put 25,200 -47.39 2,430 -58.15 n/a n/a n/a
2023-11-21 2023-09-30 13F/A SAREPTA THERAPEUTICS COM Put 47,900 24.74 5,806 32.04 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Put 47,900 5,806 n/a n/a n/a
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM Put 38,400 -74.60 4,398 -78.90 n/a n/a n/a
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM Put 151,200 82.17 20,840 93.76 n/a n/a n/a
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM Put 83,000 -3.04 10,755 13.67 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM Put 85,600 9,462 n/a n/a n/a
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM Put 1,400 -87.83 126 -88.16 n/a n/a n/a
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM Put 11,500 -53.63 1,064 -44.81 n/a n/a n/a
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS COM Put 24,800 320.34 1,928 338.18 n/a n/a n/a
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS COM Put 5,900 5,800.00 440 2,488.24 n/a n/a n/a
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM Put 100 -95.65 17 -94.74 n/a n/a n/a
2020-11-16 2020-09-30 13F SAREPTA THERAPEUTICS COM Put 2,300 4.55 323 -8.50 n/a n/a n/a
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS COM Put 2,200 -89.91 353 -83.44 n/a n/a n/a
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM Put 21,800 1,111.11 2,132 818.97 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM Put 1,800 260.00 232 510.53 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Put 500 38 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM Put 2,100 -12.50 250 -4.58 n/a n/a n/a
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM Put 2,400 -22.58 262 -47.70 n/a n/a n/a
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM Put 3,100 675.00 501 845.28 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM Put 400 53 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.